Concepedia

Publication | Closed Access

Inhibition of Liver Cancer HepG2 Cell Proliferation by EnzymaticallyPrepared Low-molecular Citrus Pectin

DOI

15

Citations

0

References

2021

Year

Xiaoqian Wu, Jiaying Fu, Ruyi Mei, Xianjun Dai, Junhui Li, Xiaofeng Zhao, Mingqi Liu
Current Pharmaceutical Biotechnology

Abstract

The enzymatically prepared LCP could inhibit the proliferation of HepG2 cells. This study provided a partial experimental basis and reference for LCP to become a potential functional food for anti-liver cancer.